menu
    • menu
    [{"orgOrder":0,"company":"Lacer","sponsor":"Lacer","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Carvacrol","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase I","graph3":"Lacer","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Gargle\/Mouthwash","sponsorNew":"Lacer \/ Lacer","highestDevelopmentStatusID":"6","companyTruncated":"Lacer \/ Lacer"},{"orgOrder":0,"company":"Lacer","sponsor":"Lacer","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"CHX","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Lacer","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lacer \/ Lacer","highestDevelopmentStatusID":"6","companyTruncated":"Lacer \/ Lacer"}]

    Find Clinical Drug Pipeline Developments & Deals by Lacer

    Menu

    Lacer

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Lacer

                            Spain arrow
                            ChemOutsourcing
                            Not Confirmed

                            Lacer

                            Spain arrow
                            ChemOutsourcing
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : CHX

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Recipient : University of Santiago de Compostela

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            May 31, 2024

                            Lead Product(s) : CHX

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Recipient : University of Santiago de Compostela

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Lacer

                            Spain arrow
                            ChemOutsourcing
                            Not Confirmed

                            Lacer

                            Spain arrow
                            ChemOutsourcing
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Carvacrol

                            Therapeutic Area : Dental and Oral Health

                            Study Phase : Phase I

                            Recipient : University of Santiago de Compostela

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            August 30, 2022

                            Lead Product(s) : Carvacrol

                            Therapeutic Area : Dental and Oral Health

                            Highest Development Status : Phase I

                            Recipient : University of Santiago de Compostela

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth